The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators, and Myostatin Inhibitors

    June 2022 in “ 대한스포츠의학회지 ”
    Jeremy Park, Vera Mcllvain, Jared Rosenberg … Joon Young Kim
    Studysummary This article reviews the development of selective androgen receptor modulators and myostatin inhibitors as performance-enhancing drugs, highlighting ongoing challenges in achieving truly tissue-selective anabolic agents and reporting no new experimental findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on kjsm.org →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Transforming Growth Factor-Beta in Stem Cells and Tissue Homeostasis Bone Research · 2018
    2. Selective Androgen Receptor Modulator, YK11, Up-Regulates Osteoblastic Proliferation and Differentiation in MC3T3-E1 Cells Biological and Pharmaceutical Bulletin · 2018
    3. Beyond Testosterone Cypionate: Evidence Behind the Use of Nandrolone in Male Health and Wellness Translational Andrology and Urology · 2016
    4. Ornithine Decarboxylase Is Upregulated by the Androgen Receptor in Skeletal Muscle and Regulates Myoblast Proliferation AJP Endocrinology and Metabolism · 2011
    5. Pharmacology of Anabolic Steroids British Journal of Pharmacology · 2008
    6. Male Androgenetic Alopecia Clinical and Experimental Dermatology · 2002